Status:
UNKNOWN
Study of Olfactory Disorders in Patients With Cardiac Amyloidosis
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Conditions:
Amyloidosis
Cardiac Amyloidosis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Amyloidosis is a disease caused by the continuous accumulation of fibrillary proteins in the extracellular matrix causing the architecture of different organs to be disrupted. The prevalence of the di...
Eligibility Criteria
Inclusion
- Age\>18 years
- Affiliated with Social Security
- Patient who was informed of the study and signed a free and informed consent
- Patients diagnosed with AC
Exclusion
- \- Refusal to participate in the study
- Patient who does not speak or understand French
- History of chronic rhino sinusitis with or without polyps
- A history of counter-indicating the completion of nasal endoscopy (repeated epistaxis, obstructive naso-sinusal tumors, choanal imperforation)
- History of major craniofacial trauma resulting in loss of smell
- Known history of Parkinson's disease or Alzheimer's disease
- Antecedent of ENT radiotherapy
- History of chemotherapy
- Patient under guardianship, curatorship or legal protection
- Patient on AME
- Pregnant or lactating women
Key Trial Info
Start Date :
March 19 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2022
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT04661800
Start Date
March 19 2021
End Date
December 1 2022
Last Update
March 10 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Assistance Publique Hôpitaux de Paris - CHU HENRI MONDOR
Créteil, France, 94010